Preventing Prostate Cancer

Preventing Prostate Cancer: Clinically Proven Lifestyle Advice for UK Men

Bionutrica UK / 18/08/2025

    Introduction

    Prostate cancer is the most common cancer among men in the UK, with more than 52,000 new cases diagnosed each year according to Cancer Research UK. While genetics and age play a role, growing evidence shows that lifestyle choices can significantly influence prostate health and long-term cancer risk.

    The good news? Men can take proactive steps to lower their chances of developing prostate cancer through everyday habits. This article unpacks the latest clinical research on diet, exercise, and supplementation, giving men over 40 practical strategies to safeguard their health

    Why Prostate Cancer Prevention Matters

    By the age of 50, half of men show signs of benign prostatic hyperplasia (BPH)  a non-cancerous enlargement of the prostate. Although BPH is not prostate cancer, both conditions share risk factors such as chronic inflammation, hormonal imbalances, and poor metabolic health.

    In the UK, prostate cancer survival rates are improving, but prevention remains crucial. Simple lifestyle changes not only reduce risk but also improve quality of life, supporting urinary health, energy levels, and overall well being.

    The Science Behind Prostate Health

    The prostate is a walnut-sized gland that supports male reproductive function. As men age, declining testosterone and rising dihydro testosterone (DHT) levels contribute to prostate growth and inflammation.

    Research links metabolic syndrome  obesity, high blood sugar, and poor lipid balance – with greater prostate cancer risk. This suggests the prostate is not just a reproductive organ, but also a marker of systemic health.

    Early Warning Signs to Watch

    Prostate issues often develop silently. Symptoms such as frequent night-time urination, weak urinary flow, or pelvic discomfort are easy to dismiss. Yet catching changes early is vital.

    According to the NHS, men should consult their GP if they notice urinary difficulties, blood in semen, or persistent lower back pain. Awareness and screening play a major role in early detection and prevention.

    Lifestyle & Nutritional Strategies

    1. Adopt a Mediterranean-style Diet

    Multiple studies suggest a diet rich in vegetables, fruits, whole grains, legumes, and oily fish reduces prostate cancer risk. Tomatoes (lycopene), Brazil nuts (selenium), and pumpkin seeds (zinc) stand out for their protective effects.

    2. Stay Physically Active

    Men who engage in regular exercise have lower rates of BPH and slower prostate cancer progression. Exercise reduces insulin resistance and inflammation, both of which influence prostate health.

    3. Manage Stress Effectively

    Chronic stress raises cortisol, which can worsen hormonal imbalance and inflammation. UK-based mindfulness programmes, meditation, and yoga are increasingly recommended for men’s health.

    4. Maintain a Healthy Weight

    Obesity is a known risk factor for aggressive prostate cancer. Keeping a healthy BMI through balanced eating and activity is one of the strongest preventive measures.

    Supplements & Clinical Evidence

    While no supplement can guarantee prevention, several natural compounds show promise in supporting prostate health when combined with lifestyle measures:

    • Saw Palmetto: Inhibits conversion of testosterone to DHT, easing urinary symptoms in clinical trials.

    • Beta-Sitosterol: A plant sterol shown to improve urinary flow and reduce discomfort.

    • Zinc: Essential for prostate integrity, though supplementation should be moderate.

    • Lycopene: A tomato-derived antioxidant linked to reduced prostate cancer risk.

    • Curcumin: Found in turmeric, it has anti-inflammatory properties and supports healthy cellular signalling.

    The Philosophy of Supplementation

    Supplements are not quick fixes. They work best when seen as part of a long-term prevention strategy alongside a nutrient-rich diet, regular exercise, and stress reduction. For UK men over 40, supplements may offer a valuable layer of support – but only when chosen wisely, with clinically tested formulations.

    FAQs on Prostate Cancer Prevention (UK)

    1. What is the biggest risk factor for prostate cancer?

    Age is the strongest risk factor. Most cases occur in men over 50. Family history and ethnicity also play important roles.

    2. Can diet really reduce prostate cancer risk?

    Yes. Research supports diets high in fruit, vegetables, whole grains, and oily fish. Lycopene (tomatoes), selenium (Brazil nuts), and cruciferous vegetables like broccoli may offer added protection.

    3. Does exercise help prevent prostate cancer?

    Regular physical activity lowers inflammation and improves hormone balance, reducing risk of prostate enlargement and cancer progression. Even brisk walking several times a week can make a difference.

    4. Should I take supplements to protect my prostate?

     Supplements like saw palmetto, beta-sitosterol, zinc, and lycopene show clinical promise. However, they should complement not replace a balanced diet and healthy lifestyle. Always consult your GP before starting new supplements.

    5. When should I get checked for prostate cancer in the UK?

    The NHS does not run a national screening programme, but men over 50 can request a PSA blood test from their GP. Men with a family history or higher risk (such as Black men) may consider earlier testing.

    6. Is prostate cancer preventable?

     No single strategy guarantees prevention, but adopting a healthy lifestyle diet, exercise, weight management, and stress control can significantly reduce your risk.

    Conclusion

    Prostate cancer prevention is not about waiting for symptoms; it’s about acting early with evidence-based choices. By embracing a Mediterranean diet, staying active, managing stress, and considering targeted supplementation, men in the UK can take control of their prostate health.

    Awareness, early detection, and lifestyle synergy form the foundation of long-term well being  ensuring not just a longer life, but a healthier and more confident one.

    Author Attributions

    Written by the BioNutrica Editorial Team based upon secondary research using the following articles:

    1. Parsons, J. K., et al. (2013). Lifestyle factors, benign prostatic hyperplasia, and lower urinary tract symptoms. Current Opinion in Urology, 23(1), 1–5.

    2. Roehrborn, C. G. (2005). Benign prostatic hyperplasia: An overview. Reviews in Urology, 7(Suppl 9), S3–S14.

    3. McVary, K. T., et al. (2006). Update on AUA guideline on the management of benign prostatic hyperplasia. Journal of Urology, 175(3), 1106–1108.

    4. Andriole, G. L., et al. (2010). Effect of dutasteride on the risk of prostate cancer. NEJM, 362(13), 1192–1202.

    5. Wilt, T. J., et al. (1998). Saw palmetto extracts for treatment of benign prostatic hyperplasia: A systematic review. JAMA, 280(18), 1604–1609.

    6. Berges, R. R., et al. (1995). Randomized, placebo-controlled, double-blind clinical trial of beta-sitosterol in patients with benign prostatic hyperplasia. The Lancet, 345(8964), 1529–1532.

    7. Kristal, A. R., et al. (2010). Baseline selenium status and effects of selenium and vitamin E supplementation on prostate cancer risk. JNCI, 102(5), 353–355.

    8. Bosland, M. C. (2005). The role of dietary fat in prostate cancer risk. Clinical Prostate Cancer, 4(2), 91–97.

    9. Zlotta, A. R., et al. (2006). The effect of aging and lifestyle on the function and structure of the prostate. Aging Male, 9(3), 157–163.

    10. Henkel, R. et al. (2008). Influence of oxidative stress on the male reproductive tract. Andrologia, 40(2), 63–75.

    11. Kulkarni, S. K., et al. (2008). Curcumin: A promising natural compound with anti-inflammatory properties. Int J Clin Pharmacol Ther, 46(10), 585–597.

    12. Gupta, S. C., et al. (2013). Therapeutic roles of curcumin: Lessons learned from clinical trials. AAPS Journal, 15(1), 195–218.

    13. Zhang, W., et al. (2015). The role of inflammation in benign prostatic hyperplasia development among Chinese men. Aging Male, 18(2), 104–108.